| Activity | | | |
|---|
| Prescription Drug User Fee Act (PDUFA) | 2015 | 2014 | 2013 |
|---|
| New Drug Application (With Clinical Data) | $2,335,200 | $2,169,100 | $1,958,800 |
| New Drug Application (Without Clinical Data) | $1,167,600 | $1,084,550 | $979,400 |
| New Drug Application Supplement With Clinical Data | $1,167,600 | $1,084,550 | $979,400 |
| NDA Establishment | $569,200 | $554,600 | $526,500 |
| Annual Product Registration | $110,370 | $104,060 | $98,380 |
| Medical Device User Fee Act (MDUFA) | 2015 | 2014 | 2013 |
|---|
| Premarket Application | $250,895 | $258,520 | $248,000 |
| Product Development Protocol | $250,895 | $258,520 | $248,000 |
| Biologics Licensing Application | $250,895 | $258,520 | $248,000 |
| Premarket Report | $250,895 | $258,520 | $248,000 |
| BLA Efficacy Supplement | $250,895 | $258,520 | $248,000 |
| Panel-Track Supplement | $188,171 | $193,890 | $186,000 |
| 180-Day Supplement | $37,634 | $38,778 | $37,200 |
| Real-Time Supplement | $17,563 | $18,096 | $17,360 |
| 510(k) Premarket Notification Submission | $5,018 | $5,170 | $4,960 |
| 30-Day Notice | $4,014 | $4,136 | $3,968 |
| 513(g) Request for Classification Information | $3,387 | $3,490 | $3,348 |
| Annual Fee for Class III Device | $8,781 | $9,048 | $8,680 |
| Annual Establishment Registration | $3,646 | $3,313 | $2,575 |
| Generic Drug User Fee Act (GDUFA) | 2015 | 2014 | 2013 |
|---|
| Abbreviated New Drug Application | $58,730 | $63,860 | $51,520 |
| Prior Approval Supplement | $29,370 | $31,930 | $25,760 |
| Drug Master File | $26,720 | $31,460 | $21,340 |
| Finished Dosage Form Facility (Domestic) | $247,717 | $220,152 | $175,389 |
| Finished Dosage Form Facility (Foreign) | $262,717 | $235,152 | $190,389 |
| Active Pharmaceutical Ingredient Facility (Domestic) | $41,926 | $34,515 | $26,458 |
| Active Pharmaceutical Ingredient Facility (Foreign) | $56,926 | $49,515 | $41,458 |
| Biosimilar User Fee Act (BsUFA) | 2015 | 2014 | 2013 |
|---|
| Biosimilar Application (Requiring Clinical Data) | $2,335,200 | $2,169,100 | $1,958,800 |
| Biosimilar Application (Not Requiring Clinical Data) | $1,167,600 | $1,084,550 | $979,400 |
| Biosimilar Supplement (Requiring Clinical Data) | $1,167,600 | $1,084,550 | $979,400 |
| Biological Product Development (Initial) | $233,520 | $216,910 | $195,880 |
| Biological Product Development (Annual) | $233,520 | $216,910 | $195,880 |
| Biological Product Development (Reactivation) | $467,040 | $433,820 | $391,760 |
| Establishment Fee | $569,200 | $554,600 | $526,500 |
| Product Fee | $110,370 | $104,060 | $98,380 |
| Animal Drug User Fee Act (ADUFA) | 2015 | 2014 | 2013 |
|---|
| Animal Drug Application (New) | $400,600 | $396,600 | $435,200 |
| Animal Drug Application (Supplement) | $200,300 | $198,300 | $217,600 |
| Animal Drug Product Fee | $8,075 | $9,075 | $8,640 |
| Animal Drug Establishment Fee | $104,150 | $105,800 | $104,600 |
| Animal Drug Sponsor Fee | $94,450 | $101,150 | $87,700 |
| Animal Generic Drug User Fee Act (AGDUFA) | 2015 | 2014 | 2013 |
|---|
| Abbreviated Application Fee for Generic New Animal Drug except those subject to the criteria in section 512(d)(4) | $189,200 | $177,900 | $148,300 |
| Abbreviated Application Fee for Generic New Animal Drug subject to the criteria in section 512(d)(4) | $94,600 | $88,950 | N/A |
| Generic New Animal Drug Product Fee | $8,500 | $8,035 | $6,515 |
| Sponsor Fee (Seven or More Approved Products) | $80,900 | $72,800 | $63,000 |
| Sponsor Fee (Three or More Approved Products) | $60,675 | $54,600 | $47,250 |
| Sponsor Fee (One or Fewer Approved Products) | $40,450 | $36,400 | $31,500 |
| Outsourcing Facility Fee | 2015 | 2014 | 2013 |
|---|
| Qualified Small Business Establishment Fee | $5,103 | N/A | N/A |
| Non-Small Business Establishment Fee | $16,442 | N/A | N/A |
| Reinspection Fee | $15,308 | N/A | N/A |